OptimizeRx Corp - Common Stock (OPRX)

Q1 2022 13F Holders as of 3/31/2022

Type / Class
Equity / Common Stock
Shares outstanding
18.5M
Number of holders
139
Total 13F shares, excl. options
15.4M
Shares change
+560K
Total reported value, excl. options
$581M
Value change
+$1.66M
Put/Call ratio
1.46
Number of buys
79
Number of sells
-88
Price
$37.71

Significant Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q1 2022

198 filings reported holding OPRX - OptimizeRx Corp - Common Stock as of Q1 2022.
OptimizeRx Corp - Common Stock (OPRX) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15.4M shares of 18.5M outstanding shares and own 83.18% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.68M shares), VANGUARD GROUP INC (1.12M shares), Artisan Partners Limited Partnership (828K shares), BLAIR WILLIAM & CO/IL (726K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (653K shares), STATE STREET CORP (605K shares), AMERICAN CENTURY COMPANIES INC (589K shares), Handelsbanken Fonder AB (545K shares), G2 Investment Partners Management LLC (534K shares), and Granite Investment Partners, LLC (430K shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.